1. Home
  2. AGL vs AORT Comparison

AGL vs AORT Comparison

Compare AGL & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo agilon health inc.

AGL

agilon health inc.

N/A

Current Price

$82.12

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo Artivion Inc.

AORT

Artivion Inc.

N/A

Current Price

$22.03

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AGL
AORT
Founded
2016
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
AGL
AORT
Price
$82.12
$22.03
Analyst Decision
Buy
Strong Buy
Analyst Count
15
8
Target Price
★ $118.33
$42.15
AVG Volume (30 Days)
168.2K
★ 478.4K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 165.62
EPS
★ 3.96
N/A
Revenue
★ $5,932,576,000.00
$298,836,000.00
Revenue This Year
N/A
$11.12
Revenue Next Year
$7.17
$10.77
P/E Ratio
$19.73
★ N/A
Revenue Growth
N/A
★ 18.01
52 Week Low
$0.30
$19.16
52 Week High
$133.04
$48.25

Technical Indicators

Market Signals
Indicator
AGL
AORT
Relative Strength Index (RSI) 38.17 37.66
Support Level $72.16 $22.83
Resistance Level $98.63 $25.04
Average True Range (ATR) 5.08 0.87
MACD -0.64 -0.08
Stochastic Oscillator 31.07 20.96

Price Performance

Historical Comparison
AGL
AORT

About AGL agilon health inc.

Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: